Page 1

Interim report January - June 2026 surgicalscience Surgical Science is a global leader in evidence - based medical simulation . The company's virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes . Also , Surgical Science partners with medical device and robotics companies to integrate tailor - made simulation technology into their devices , helping them accelerate innovation and gain a competitive edge . Surgical Science has approximately 320 employees . The company's head office is located in Gothenburg , Sweden , with operations also in Tel Aviv , Israel ; Stockholm , Sweden ; Cleveland , USA ; Cardiff , UK ; as well as Hong Kong and Shenzhen , China . Through sales offices in these markets as well as a global network of distributors , Surgical Science maintains a presence in most markets . Shares in Surgical Science Sweden AB ( publ ) are traded on Nasdaq First North Growth Market , Stockholm , Sweden . Certified Adviser is DNB Carnegie Investment Bank AB .